Precision Optics Corporation, Inc. (POCI) Key Metrics

NASDAQ: POCIValuation, returns, debt and efficiency ratios over 10 years.

POCI valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$47.4M
Enterprise value
$43.8M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
1.5
10-yr median 1.8
Price / book
2.5
10-yr median 3.7
EV / EBITDA
129.5
Dividend yield
—
Beta
0.34

POCI key metrics, FY2017–FY2026

Fiscal year ended June 30, 2026 · U.S. dollars

POCI valuation Price multiples at each fiscal year-end price.

Price / sales−20.8%
1.4
FY2026 · hover or tap a bar for each year
FY2017: 1.6 (+63.8%)FY2018: 1.3 (−18.7%)FY2019: 1.9 (+49.2%)FY2020: 1.9 (−1.3%)FY2021: 2.1 (+10.0%)FY2022: 2.0 (−3.5%)FY2023: 1.7 (−17.9%)FY2024: 1.9 (+13.2%)FY2025: 1.7 (−7.0%)FY2026: 1.4 (−20.8%)
FY2017FY2026
Price / book−21.2%
2.1
FY2026 · hover or tap a bar for each year
FY2017: 9.0 (+38.8%)FY2018: 9.2 (+3.0%)FY2019: 3.9 (−58.0%)FY2020: 6.8 (+75.4%)FY2021: 6.5 (−4.4%)FY2022: 3.5 (−45.8%)FY2023: 2.9 (−17.9%)FY2024: 3.6 (+22.9%)FY2025: 2.7 (−23.7%)FY2026: 2.1 (−21.2%)
FY2017FY2026
Free cash flow yield+6.8 pts
−4.5%
FY2026 · hover or tap a bar for each year
FY2017: −14.0% (+9.3 pts)FY2018: 1.5% (+15.5 pts)FY2019: −9.0% (−10.5 pts)FY2020: −4.0% (+5.0 pts)FY2021: −0.3% (+3.7 pts)FY2022: −3.4% (−3.1 pts)FY2023: −0.4% (+3.1 pts)FY2024: −8.3% (−7.9 pts)FY2025: −11.3% (−3.0 pts)FY2026: −4.5% (+6.8 pts)
FY2017FY2026

POCI valuation history

Fiscal year-endToday10-year median

POCI returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

POCI debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

POCI price vs earnings per share

Share price at year-endEPS (right axis)

POCI key metrics

FY2017–FY2026
Precision Optics Corporation, Inc. key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$43.5M$33.3M$35.8M$34.8M$31.6M$22.3M$18.8M$13.1M$5.2M$5.0M
Enterprise value$37.7M$33.5M$38.8M$35.1M$34.0M$21.7M$18.7M$10.8M$4.8M$4.9M
Price / sales1.41.71.91.72.02.11.91.91.31.6
Price / book2.12.73.62.93.56.56.83.99.29.0
Price / free cash flow————————65.9—
Price / operating cash flow—————479.3——51.7—
EV / sales1.21.82.01.72.22.01.91.61.21.6
EV / EBITDA———122.2—432.5————
EV / free cash flow————————61.1—
Earnings yield−8.3%−17.4%−8.2%−0.4%−2.9%−0.5%−7.6%−4.7%−6.7%−20.1%
Free cash flow yield−4.5%−11.3%−8.3%−0.4%−3.4%−0.3%−4.0%−9.0%1.5%−14.0%
Share price at fiscal year-end$5.10$4.90$5.90$6.15$5.97$5.04$4.35$3.42$1.59$1.80
Per share
Revenue per share$3.70$2.81$3.15$3.71$2.96$2.41$2.29$1.78$1.23$1.13
Earnings per share−$0.43−$0.85−$0.49−$0.03−$0.18−$0.02−$0.33−$0.16−$0.11−$0.36
Operating cash flow per share−$0.18−$0.52−$0.44−$0.01−$0.18$0.01−$0.14−$0.27$0.03−$0.24
Free cash flow per share−$0.23−$0.56−$0.49−$0.02−$0.21−$0.02−$0.17−$0.31$0.02−$0.25
Cash per share$1.15$0.26$0.07$0.52$0.11$0.19$0.26$0.60$0.12$0.04
Book value per share$2.39$1.81$1.66$2.13$1.69$0.78$0.64$0.88$0.17$0.20
Tangible book value per share$1.33$0.47$0.16$0.52−$0.02$0.59$0.46$0.69$0.16$0.19
Capex per share$0.05$0.03$0.05$0.01$0.03$0.03$0.04$0.04$0.01$0.01
Debt per share$0.48$0.30$0.57$0.56$0.57$0.06$0.23$0.00$0.01$0.01
Shares outstanding8.5M6.8M6.1M5.7M5.3M4.4M4.3M3.8M3.3M2.8M
Change in shares outstanding+25.6%+11.9%+7.1%+7.0%+19.6%+2.2%+13.2%+16.9%+17.8%+16.6%
Returns & profitability
Return on equity (ROE)−22.3%−51.8%−26.7%−1.4%−15.0%−3.3%−46.4%−31.2%−62.6%−175.7%
Return on invested capital (ROIC)−20.5%−34.2%−17.0%−4.3%−15.1%−26.1%−59.9%−75.1%−83.9%−151.0%
Return on assets (ROA)−13.9%−31.5%−16.1%−0.8%−8.1%−1.6%−20.6%−12.3%−16.3%−51.3%
Return on tangible assets−15.6%−53.9%−37.8%−1.4%−12.1%−1.9%−25.6%−9.1%−14.3%−56.8%
Free cash flow margin−6.3%−19.8%−15.6%−0.6%−6.9%−0.7%−7.6%−17.3%2.0%−22.3%
Financial health
Total debt$4.1M$2.0M$3.4M$3.2M$3.0M$251,991$1.0M$14,599$23,563$31,955
Cash & short-term investments$9.8M$1.8M$405,278$2.9M$605,749$861,650$1.1M$2.3M$402,738$118,405
Net debt−$5.8M$262,685$3.0M$233,515$2.4M−$609,659−$119,761−$2.3M−$379,175−$86,450
Debt / equity0.200.170.340.260.330.070.370.000.040.06
Debt / assets0.130.100.200.160.180.040.160.000.010.02
Net debt / EBITDA———0.81—−12.15————
Current ratio2.281.641.451.871.421.901.571.761.251.39
Quick ratio1.841.060.871.350.761.150.871.280.660.53
Interest coverage-23.7-24.5-12.1-2.9-8.7-170.8—-432.6-187.5-318.8
Working capital$11.3M$3.9M$2.2M$4.6M$1.9M$2.3M$1.8M$2.8M$481,876$479,604
Invested capital$14.6M$12.5M$13.1M$12.3M$11.4M$2.8M$2.7M$1.1M$184,861$471,930
Tangible asset value$11.3M$3.2M$957,019$3.0M−$82,113$2.6M$2.0M$2.6M$516,761$528,294
Net current asset value$8.1M$2.5M$273,447$2.2M−$1.2M$1.9M$1.4M$2.3M$467,275$456,040
Graham net-net per share$0.50−$0.11−$0.39−$0.08−$0.68$0.09−$0.05$0.17−$0.11−$0.09
Capital allocation
Capex / revenue1.4%1.2%1.5%0.2%1.0%1.1%1.6%2.2%0.5%1.1%
Capex / operating cash flow—————262.9%——21.5%—
Capex / depreciation1.531.071.380.250.800.831.433.810.801.04
Stock-based compensation / revenue3.6%7.6%5.0%4.4%5.8%6.9%5.1%7.0%1.3%6.4%
R&D / revenue3.3%6.1%5.1%4.7%4.3%5.8%8.9%7.4%11.3%14.7%
SG&A / revenue—40.8%39.5%35.1%35.8%34.8%39.3%30.9%——
Efficiency
Days sales outstanding59.575.371.257.052.957.467.179.457.270.5
Days of inventory on hand51.774.877.479.583.3102.9109.4112.2157.0167.8
Days payables outstanding45.450.152.564.158.557.262.373.299.8141.5
Cash conversion cycle (days)65.8100.196.172.477.7103.1114.1118.5114.496.8
Receivables turnover6.134.845.136.406.906.355.444.596.385.18
Payables turnover8.047.296.955.706.246.385.864.993.662.58
Inventory turnover7.064.884.724.594.383.553.343.252.322.18
Asset turnover1.211.041.041.151.371.691.431.361.871.61
Average receivables$5.1M$3.9M$3.7M$3.3M$2.3M$1.7M$1.8M$1.5M$632,736$609,464
Average payables$3.2M$2.2M$1.9M$2.3M$1.7M$1.1M$1.1M$938,900$699,248$923,260
Average inventory$3.7M$3.2M$2.8M$2.9M$2.5M$2.0M$2.0M$1.4M$1.1M$1.1M
Intangibles / total assets27.9%45.8%53.9%46.0%54.2%13.2%12.3%9.9%1.9%1.7%

Computed from POCI's annual financial statements (latest annual report filed September 28, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

POCI valuation and financial ratios

Precision Optics earned a return on equity of −22.3% and a return on invested capital of −20.5% in fiscal 2026. It ended the year with $4.1 million of debt and $9.8 million in cash and short-term investments, a net cash position of $5.8 million. The share count rose 206.7% from 2.8M to 8.5M over 9 years.

See the POCI income statement, the POCI chart for price history, or the POCI stock overview for the latest quote and news.

POCI key metrics FAQ

What is Precision Optics's return on equity?

Precision Optics's return on equity (ROE) was −22.3% in fiscal 2026: net income of -$3.6 million on average shareholders' equity of $16.3 million.

What is Precision Optics's ROIC?

Precision Optics's return on invested capital was −20.5% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Precision Optics have?

Precision Optics had total debt of $4.1 million at the end of fiscal 2026, a debt-to-equity ratio of 0.20 and more cash than debt.

What is Precision Optics's free cash flow yield?

Precision Optics generated -$2.0 million of free cash flow in fiscal 2026, a free cash flow yield of −4.5% on its market value at year-end ($43.5 million).

What is Precision Optics's current ratio?

Precision Optics's current ratio was 2.28 at the end of fiscal 2026: current assets were 2.28 times current liabilities.

Medical Instruments & Supplies key metrics